Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Department of Urology, Helsinki University Hospital, Helsinki, Finland; Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Eur Urol Oncol. 2018 Dec;1(6):461-466. doi: 10.1016/j.euo.2018.06.002. Epub 2018 Jun 30.
Family risks for urinary tract cancers (excluding kidney cancers) are known, but less is known about whether rare urinary tract cancer subtypes are also familial and if urinary tract cancers share familial risk for other (discordant) cancers.
To investigate the impact of family history on urinary tract cancers (International Classification of Diseases version 7 code 181) and discordant cancers.
DESIGN, SETTING, AND PARTICIPANTS: The Swedish Family-Cancer Database, the largest family data set in the world, was used to assess familial risks between 86 058 patients with urinary tract cancers and patients with other cancers between 1958 and 2015.
A Poisson regression model was used to generate relative risks (RRs).
Some 7.0% of patients with urinary tract cancers had a parent or sibling diagnosed with the same cancer, yielding an RR of 1.81 (95% confidence interval [CI] 1.68-1.94). As novel familial findings, we also found that ureter (RR 1.62, 95% CI 1.04-2.53) and transitional cell in situ tumors (RR 2.04, 95% CI 1.49-2.80) were associated with urinary tract cancers. The most consistent discordant familial associations of urinary tract cancers were with smoking-related sites of cancer: lung, stomach, and kidney. Internally consistent familial associations not related to smoking were found for endometrial and thyroid cancers. Familial associations with urinary tract cancers were also found for rare anal, female genital, and cervical cancers. The main limitation was a lack of data on smoking.
Smoking-related cancers were associated with urinary tract cancer. We speculate that familial clustering of endometrial and thyroid cancers with urinary tract cancers may be ascribed to obesity.
Diagnosis of bladder cancer in a close family member may be a sign of higher risk among other family members. Patients and family members should be told that bladder cancer is smoking-related and they should be counseled to recognize blood in urine as a possible early sign.
已知某些家族存在患泌尿系统癌症(不包括肾癌)的风险,但对于某些罕见的泌尿系统癌症亚型是否也具有家族遗传性,以及泌尿系统癌症是否与其他(不同的)癌症存在家族共患风险,人们知之甚少。
探讨家族史对泌尿系统癌症(国际疾病分类第 7 版代码 181)和不同癌症的影响。
设计、地点和参与者:本研究使用世界上最大的家族数据库——瑞典家族癌症数据库,评估了 1958 年至 2015 年间 86058 例泌尿系统癌症患者与其他癌症患者之间的家族风险。
采用泊松回归模型计算相对风险(RR)。
约 7.0%的泌尿系统癌症患者有父母或兄弟姐妹被诊断出患有相同的癌症,RR 为 1.81(95%置信区间[CI] 1.68-1.94)。作为新的家族发现,我们还发现输尿管(RR 1.62,95%CI 1.04-2.53)和移行细胞原位肿瘤(RR 2.04,95%CI 1.49-2.80)与泌尿系统癌症有关。与泌尿系统癌症最一致的不一致家族关联是与吸烟相关的癌症部位:肺癌、胃癌和肾癌。与吸烟无关的子宫内膜癌和甲状腺癌也存在一致的家族关联。与泌尿系统癌症相关的家族关联也存在于罕见的肛门癌、女性生殖道癌和宫颈癌中。主要局限性是缺乏吸烟数据。
与吸烟相关的癌症与泌尿系统癌症相关。我们推测,子宫内膜癌和甲状腺癌与泌尿系统癌症的家族聚集可能归因于肥胖。
近亲诊断出膀胱癌可能是其他家族成员存在更高风险的迹象。应告知患者和家属膀胱癌与吸烟有关,应指导他们认识到血尿可能是早期症状。